ריטלין טבליות 10 מג
novartis israel ltd - methylphenidate hydrochloride - טבליה - methylphenidate hydrochloride 10 mg - methylphenidate - methylphenidate - attention deficit hyperactivity disorder (adhd). narcolepsy.
קונסרטה 18 מג
j-c health care ltd - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 18 mg - methylphenidate - methylphenidate - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd).
קונסרטה 36 מג
j-c health care ltd - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 36 mg - methylphenidate - methylphenidate - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd).
קונסרטה 54 מג
j-c health care ltd - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 54 mg - methylphenidate - methylphenidate - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd).
ריטלין la ® 40 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).
ריטלין la ® 30 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 30 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).
ריטלין la ® 20 מ"ג כמוסות בשחרור מושהה
novartis pharma services ag - methylphenidate hydrochloride 20 mg - capsules - methylphenidate - attention deficit hyperactivity disorder (adhd).
קונסרטה 27 מג
j-c health care ltd - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 27 mg - methylphenidate - methylphenidate - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd).
מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג
mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.
מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג
mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.